D

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Thought Leader Liaison - Northeast

Product MarketingConfirmed live in the last 24 hours
Full-timeUnited States$230k - $260k

About the Job

Requirements

  • A bachelor's degree is required; an advanced degree is preferred.
  • At least 10 years of experience in biotechnology or pharmaceutical commercial roles is required.
  • Experience engaging neuromuscular or rare disease thought leaders in a commercial context is required.
  • Strong understanding of the rare disease commercialization landscape, including diagnosis complexity, referral dynamics, and patient advocacy, is required.
  • Ability to translate complex scientific and clinical insights into clear, innovative, and actionable commercial strategies is required.
  • Ability to deliver results in therapeutic areas with high unmet need is required.
  • Interpersonal, oral, and written communication skills, execution focus, executive presence, and ability to influence without authority are required.
  • Cross-functional collaboration skills and experience operating in matrixed organizations are required.
  • Commitment to ethical, compliant engagement practices is required.
  • Ability to manage a large geographical territory is required.
  • Must reside within the assigned territory and within reasonable driving distance of a major commercial airport capable of supporting frequent regional and national travel.
  • Domestic travel up to 80% is required.

Responsibilities

  • Develop and execute a comprehensive thought leader engagement strategy for rare neuromuscular diseases aligned with commercial and portfolio priorities.
  • Identify, profile, and prioritize national and regional neuromuscular thought leaders based on expertise, influence, and strategic relevance.
  • Build and sustain long-term, trust-based relationships with clinicians and experts treating rare neuromuscular disorders through compliant, value-driven engagement.
  • Serve as a credible commercial partner in discussions about disease-state education, evolving treatment paradigms, and unmet needs in neuromuscular disease.
  • Capture, synthesize, and translate thought leader insights into actionable recommendations for brand, launch, and lifecycle strategy.
  • Provide strategic input into positioning, messaging, and tactical planning that reflects the dynamics of rare disease diagnosis, treatment, and patient journeys.
  • Monitor key opinion leader insights on current and future market dynamics and competitive intelligence through customer meetings, congresses, advisory boards, and analytics.
  • Share insights with commercial leadership and cross-functional partners to inform decisions and optimize execution.
  • Lead commercial engagement strategy for key neuromuscular congresses, including pre-meeting, during-meeting, and post-meeting planning and follow-up.
  • Design and execute advisory boards, speaker programs, and peer-to-peer educational initiatives focused on rare neuromuscular disease education.
  • Identify and recruit appropriate key opinion leaders for content development and marketing projects, including web content, training, handouts, and related materials.
  • Partner cross-functionally to ensure consistency, effectiveness, and compliance across engagement forums.
  • Collaborate and interface across regions and with Sales, Marketing, Medical Affairs, Market Access, Training, Legal, and Compliance to ensure aligned and compliant execution.
  • Manage vendor partnerships as needed, including medical education agencies, meeting-services providers, and other external partners.
  • Establish metrics to assess the effectiveness, impact, and return on investment of thought leader engagement activities.
  • Ensure all interactions adhere to regulatory, legal, and company compliance standards.

Desired Qualifications

  • Experience in rare disease or specialty markets is strongly preferred.

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs